Literature DB >> 32094248

Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Laurisa Ankley1, Sean Thomas1, Andrew J Olive2.   

Abstract

Chronic bacterial infections are caused by pathogens that persist within their hosts and avoid clearance by the immune system. Treatment and/or detection of such pathogens is difficult, and the resulting pathologies are often deleterious or fatal. There is an urgent need to develop protective vaccines and host-directed therapies that synergize with antibiotics to prevent pathogen persistence and infection-associated pathologies. However, many persistent pathogens, such as Mycobacterium tuberculosis, actively target the very host pathways activated by vaccination. These immune evasion tactics blunt the effectiveness of immunization strategies and are impeding progress to control these infections throughout the world. Therefore, it is essential that M. tuberculosis immune evasion-related pathogen virulence strategies are considered to maximize the effectiveness of potential new treatments. In this review, we focus on how Mycobacterium tuberculosis infects antigen-presenting cells and evades effective immune clearance by the adaptive response through (i) manipulating antigen presentation, (ii) repressing T cell-activating costimulatory molecules, and (iii) inducing ligands that drive T cell exhaustion. In this context, we will examine the challenges that bacterial virulence strategies pose to developing new vaccines. We will then discuss new approaches that will help dissect M. tuberculosis immune evasion mechanisms and devise strategies to bypass them to promote long-term protection and prevent disease progression.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium tuberculosiszzm321990; T cell; immune evasion; intracellular pathogens; vaccine development

Year:  2020        PMID: 32094248      PMCID: PMC7309621          DOI: 10.1128/IAI.00916-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  119 in total

1.  CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection.

Authors:  Vanja Lazarevic; Amy J Myers; Charles A Scanga; JoAnne L Flynn
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

2.  Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages.

Authors:  Deepak K Nayak; Oscar Mendez; Sara Bowen; Thalachallour Mohanakumar
Journal:  J Vis Exp       Date:  2018-04-20       Impact factor: 1.355

3.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

Review 4.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

5.  Salmonella enterica Serovar Typhimurium Increases Functional PD-L1 Synergistically with Gamma Interferon in Intestinal Epithelial Cells via Salmonella Pathogenicity Island 2.

Authors:  J M Sahler; C R Eade; C Altier; J C March
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

6.  Brucella abortus down-regulates MHC class II by the IL-6-dependent inhibition of CIITA through the downmodulation of IFN regulatory factor-1 (IRF-1).

Authors:  Lis N Velásquez; M Ayelén Milillo; M Victoria Delpino; Aldana Trotta; Pablo Fernández; Roberto G Pozner; Roland Lang; Luciana Balboa; Guillermo H Giambartolomei; Paula Barrionuevo
Journal:  J Leukoc Biol       Date:  2016-10-20       Impact factor: 4.962

7.  VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.

Authors:  Georg Stary; Andrew Olive; Aleksandar F Radovic-Moreno; David Gondek; David Alvarez; Pamela A Basto; Mario Perro; Vladimir D Vrbanac; Andrew M Tager; Jinjun Shi; Jeremy A Yethon; Omid C Farokhzad; Robert Langer; Michael N Starnbach; Ulrich H von Andrian
Journal:  Science       Date:  2015-06-19       Impact factor: 47.728

Review 8.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

Review 9.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

Review 10.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

View more
  7 in total

1.  A genetic screen in macrophages identifies new regulators of IFNγ-inducible MHCII that contribute to T cell activation.

Authors:  Michael C Kiritsy; Laurisa M Ankley; Justin Trombley; Gabrielle P Huizinga; Audrey E Lord; Pontus Orning; Roland Elling; Katherine A Fitzgerald; Andrew J Olive
Journal:  Elife       Date:  2021-11-08       Impact factor: 8.140

Review 2.  Metabolic Regulation of Immune Responses to Mycobacterium tuberculosis: A Spotlight on L-Arginine and L-Tryptophan Metabolism.

Authors:  Rebecca R Crowther; Joseph E Qualls
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

Review 3.  Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment.

Authors:  Christopher G Shield; Benjamin M C Swift; Timothy D McHugh; Rebekah M Dedrick; Graham F Hatfull; Giovanni Satta
Journal:  Microorganisms       Date:  2021-11-16

Review 4.  Immune evasion and provocation by Mycobacterium tuberculosis.

Authors:  Pallavi Chandra; Steven J Grigsby; Jennifer A Philips
Journal:  Nat Rev Microbiol       Date:  2022-07-25       Impact factor: 78.297

Review 5.  Review of Pediatric Tuberculosis in the Aftermath of COVID-19.

Authors:  Patrida Rangchaikul; Phillip Ahn; Michelle Nguyen; Vivian Zhong; Vishwanath Venketaraman
Journal:  Clin Pract       Date:  2022-09-11

Review 6.  T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion.

Authors:  Freya R Shepherd; James E McLaren
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

7.  Analysis of Genomic DNA from Medieval Plague Victims Suggests Long-Term Effect of Yersinia pestis on Human Immunity Genes.

Authors:  Alexander Immel; Felix M Key; András Szolek; Rodrigo Barquera; Madeline K Robinson; Genelle F Harrison; William H Palmer; Maria A Spyrou; Julian Susat; Ben Krause-Kyora; Kirsten I Bos; Stephen Forrest; Diana I Hernández-Zaragoza; Jürgen Sauter; Ute Solloch; Alexander H Schmidt; Verena J Schuenemann; Ella Reiter; Madita S Kairies; Rainer Weiß; Susanne Arnold; Joachim Wahl; Jill A Hollenbach; Oliver Kohlbacher; Alexander Herbig; Paul J Norman; Johannes Krause
Journal:  Mol Biol Evol       Date:  2021-09-27       Impact factor: 16.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.